Fulcrum Therapeutics Inc. (FULC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fulcrum Therapeutics Inc.

    NASDAQ: FULC · Real-Time Price · USD
    9.22
    -0.29 (-3.05%)
    At close: Oct 03, 2025, 3:59 PM
    9.22
    0.00%
    After-hours: Oct 03, 2025, 05:45 PM EDT

    Fulcrum Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 58.21M 25.56M 35.1M 35.41M
    Short-Term Investments
    		 182.81M 210.66M 167.82M 182.75M
    Long-Term Investments
    		 n/a n/a 1.09M 1.09M
    Other Long-Term Assets
    		 1.21M 3.1M 2.1M 542K
    Receivables
    		 3.34M 2.25M 1.08M 4.11M
    Inventory
    		 n/a n/a -852K -473K
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 249.92M 242.2M 207.52M 226M
    Property-Plant & Equipment
    		 9.58M 12.39M 15.97M 7.37M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 10.79M 15.49M 19.17M 9M
    Total Assets
    		 260.72M 257.69M 226.69M 235M
    Account Payables
    		 1.16M 2.76M 3.64M 4.79M
    Deferred Revenue
    		 n/a n/a 934K 4.71M
    Short-Term Debt
    		 n/a n/a 2.6M n/a
    Other Current Liabilities
    		 463K 396K 2.74M 4.71M
    Total Current Liabilities
    		 11.04M 13.68M 16.73M 19.2M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 197K 197K 197K 4.26M
    Total Long-Term Liabilities
    		 6.64M 8.83M 11.02M 4.26M
    Total Liabilities
    		 17.68M 22.5M 27.74M 23.46M
    Total Debt
    		 8.63M 10.82M 13.42M n/a
    Book Value
    		 243.03M 235.19M 198.94M 211.54M
    Book Value Per Share
    		 3.92 3.84 4.42 5.98
    Common Stock
    		 54K 62K 52K 41K
    Retained Earnings
    		 -519.4M -509.67M -412.34M -302.47M
    Comprehensive Income
    		 130K -136K -797K -397K
    Shareholders Equity
    		 243.03M 235.19M 198.94M 211.54M
    Total Investments
    		 182.81M 210.66M 167.82M 182.75M

    Add to Watchlist